Genes2Me’s oncology point-of-care assay portfolio supports rapid molecular detection of key cancer-associated genetic markers used in diagnosis, prognosis, and therapy monitoring. The range includes assays for clinically significant targets such as BCR-ABL, JAK2, FLT3, PML-RARA, and HLA-B27, enabling accurate detection across hematological malignancies and related conditions. Designed for efficiency and reliability, these assays help simplify complex oncological testing workflows in decentralized and near-patient settings.
Point-of-Care PCR Kits are compatible with a wide range of clinical specimens, enabling comprehensive diagnostic testing from diverse sample types.
Whole Blood
Saliva
Nasopharyngeal Swabs
Plasma/Serum
Urine
Fresh Tissue
Other Body Fluids
Download useful documents and technical information for Point-of-Care PCR Kits.
Since its inception in 2016, Genes2me has been constantly striving towards setting a benchmark in the diagnostics space by introducing premium quality (Made in India) diagnostic kits which are CE-IVD, ISO-13485:2016, and ISO 9001:2015 certified, assuring our clients of unparalleled quality and compliance with international standards.
All products listed in the catalogue are the products of Genes2Me Private Limited. Apart from that, all other product names, trademarks and logos wherever used in the catalogue are the property of their respective owners.
© 2025 Genes2me. All rights reserved.
